Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Clinical and Regulatory Considerations for Central Venous Catheters for Hemodialysis.

Silverstein DM, Trerotola SO, Clark T, James G, Ng W, Dwyer A, Florescu MC, Shingarev R, Ash SR; Kidney Health Initiative HDF Workgroup.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1924-1932. doi: 10.2215/CJN.14251217. Epub 2018 Oct 11.

PMID:
30309840
2.

Maintenance of blood flow rate on dialysis with self-centering CentrosFLO catheter: A multicenter prospective study.

Agarwal AK, Ash SR; Principal Investigators of the CentrosFLO Trial.

Hemodial Int. 2016 Oct;20(4):501-509. doi: 10.1111/hdi.12443. Epub 2016 Jun 27.

PMID:
27346562
3.

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient.

Ash SR, Singh B, Lavin PT, Stavros F, Rasmussen HS.

Kidney Int. 2015 Aug;88(2):404-11. doi: 10.1038/ki.2014.382. Epub 2015 Feb 4.

4.

Expanding the meaning of innovation: the "Innovative Intervention Forum" section of Seminars in Dialysis.

Ash SR.

Semin Dial. 2013 Sep-Oct;26(5):614-5. doi: 10.1111/sdi.12033. Epub 2012 Nov 27. No abstract available.

PMID:
23186334
5.

Pacemaker wire central venous stenosis and one more reason to not run central venous catheters for dialysis in reverse flow.

Ash SR, Ugianskis EJ.

Semin Dial. 2013 Jan-Feb;26(1):E1-4. doi: 10.1111/j.1525-139X.2012.01114.x. Epub 2012 Aug 1.

PMID:
22860886
6.

The StenTec gauge for measuring static intra-access pressure ratio (P(Ia Ratio) ) of fistulas and grafts.

Ash SR, Dhamija R, Zaroura MY, Hentschel DM.

Semin Dial. 2012 Jul;25(4):474-81. doi: 10.1111/j.1525-139X.2011.01037.x. Epub 2012 Feb 23.

PMID:
22356546
7.

A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.

Maki DG, Ash SR, Winger RK, Lavin P; AZEPTIC Trial Investigators.

Crit Care Med. 2011 Apr;39(4):613-20. doi: 10.1097/CCM.0b013e318206b5a2.

PMID:
21200319
8.

Sorbents in treatment of uremia: a short history and a great future.

Ash SR.

Semin Dial. 2009 Nov-Dec;22(6):615-22. doi: 10.1111/j.1525-139X.2009.00657.x. Review.

PMID:
20017831
10.

In vitro and in vivo evaluation of efficacy of citrate/methylene blue/parabens/IPA solution as a skin disinfectant.

Steczko J, Ash SR, Brewer L, Guillem A.

J Infect. 2010 Jan;60(1):36-43. doi: 10.1016/j.jinf.2009.09.013. Epub 2009 Sep 22.

PMID:
19778554
11.

Lack of correlation of glucose levels in filtered blood plasma to density and conductivity measurements.

Gordon DM, Ash SR.

ASAIO J. 2009 May-Jun;55(3):227-30. doi: 10.1097/MAT.0b013e318197e844.

PMID:
19282748
12.

Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.

Sauer K, Steczko J, Ash SR.

J Antimicrob Chemother. 2009 May;63(5):937-45. doi: 10.1093/jac/dkp060. Epub 2009 Mar 12.

PMID:
19282330
13.

Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens).

Steczko J, Ash SR, Nivens DE, Brewer L, Winger RK.

Nephrol Dial Transplant. 2009 Jun;24(6):1937-45. doi: 10.1093/ndt/gfn776. Epub 2009 Jan 30.

14.

Advances in tunneled central venous catheters for dialysis: design and performance.

Ash SR.

Semin Dial. 2008 Nov-Dec;21(6):504-15. doi: 10.1111/j.1525-139X.2008.00494.x. Epub 2008 Sep 24. Review.

PMID:
19000125
15.

Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.

Moran JE, Ash SR; ASDIN Clinical Practice Committee.

Semin Dial. 2008 Sep-Oct;21(5):490-2. doi: 10.1111/j.1525-139X.2008.00466.x. Epub 2008 Aug 29.

PMID:
18764795
16.

Prediction of hemodialysis sorbent cartridge urea nitrogen capacity and sodium release from in vitro tests.

Rosenbaum BP, Ash SR, Wong RJ, Thompson RP, Carr DJ.

Hemodial Int. 2008 Apr;12(2):244-53. doi: 10.1111/j.1542-4758.2008.00261.x.

PMID:
18394059
17.

Sorbent-based artificial liver devices: principles of operation, chemical effects and clinical results.

Carpentier B, Ash SR.

Expert Rev Med Devices. 2007 Nov;4(6):839-61. Review.

PMID:
18035950
18.

The Ash Split CathTM as long-term IJ access: Hydraulic performance and longevity.

Ash SR, Mankus RA, Sutton JM, Spray M.

J Vasc Access. 2002 Jan-Mar;3(1):3-9.

PMID:
17639454
19.
20.

Aesthetic properties and message customization: navigating the dark side of web recruitment.

Dineen BR, Ling J, Ash SR, DelVecchio D.

J Appl Psychol. 2007 Mar;92(2):356-72.

PMID:
17371084

Supplemental Content

Loading ...
Support Center